DNA methylation of an imprinted control region (ICR) directs the allele-specific and reciprocal expression of the mouse H19 and the insulin-like growth factor 2 (Igf2) genes, mediated by controlling enhancer access. The ICR shows enhancer blocking activity through CTCF binding to an unmethylated sequence. The unmethylated state of the maternal ICR is maintained throughout development after establishment in the germ line; however, little is known of the molecular mechanisms that regulate DNA methylation. Hence, in this study we show that a dyad Oct-binding sequence (DOS) in the ICR mediates the demethylation of low-density methylation but not hypermethylation and is required to maintain the unmethylated state against the tendency for de novo methylation within the ICR in the embryonic carcinoma cell line P19. Furthermore, we also reveal that the unmethylated state of at least one CTCF-binding site within the ICR is under the control of DOS. Our results suggest that the ICR, as a CTCF-dependent insulator, requires DOS as well as CTCF-binding sites and that DOS maintains the maternal specific unmethylated state of the ICR at postimplantation stages.Mouse H19 and Igf2 (insulin-like growth factor 2) genes are ϳ70 kb distant from each other and are a set of imprinted genes that are reciprocally expressed only from the maternal and paternal allele, respectively, in identical tissues with the same timing. Monoallelic expression of both genes depends on differential methylation of an imprinted control region (ICR), 1 located 2-4-kb upstream of the H19 gene, that is hypermethylated in the paternal chromosome but unmethylated in the maternal chromosome. Genomic deletions of the ICR result in activation of the normally silent maternal Igf2 and paternal H19 genes in liver, gut, kidney, heart, skeletal muscle, and lung (1, 2). Additionally, deletion of endodermal enhancers downstream from the H19 gene results in loss of maternal expression of H19 and paternal Igf2 in liver, gut, and kidney (3). These results suggest that the paternal ICR represses H19 expression and that the maternal ICR represses expression of the distant Igf2 through enhancer blocking activity at least in liver, gut and kidney. In fact, recent reports revealed that a 1.2-kb portion of the methylated ICR in the paternal chromosome functioned as a transcriptional silencer in endodermal tissue (4) and that the unmethylated ICR functioned as a CTCF-dependent insulator (1, 5-7). Methylation of the CTCFbinding site inhibited binding of the CTCF protein (5, 6). Moreover, the binding of CTCF in mouse fetal liver was observed only on the maternal ICR (7). These observations suggest that the enhancer blocking activity is repressed on the hypermethylated paternal ICR, which enables association between downstream enhancers and the Igf2 promoter. Thus, the methylation status of the ICR is a crucial factor for monoallelic expression in both genes.The unmethylated state of the maternal ICR is established in the germ line and maintained during development (8 -10), although...